14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
SKHY vs DRAM: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
DRAM Captures Overall Composite Edge (49.1 HOLD vs 49.5 HOLD), While SKHY Leads 2–1 on Growth & Valuation Pillars
DRAM Overall Winner
6-Pillar Tally: SKHY 2 – 1 DRAM (3 Tie)
Matrix Metrics: SKHY 3 – 1 DRAM
As of Nov 16, 2026, DRAM (DRAM) captures the overall head-to-head institutional edge over SK hynix Inc. (SKHY) on higher Unified Composite conviction (49.1/100 HOLD vs. 49.5/100 HOLD) after splitting the core matrix 1–3 (led by Options & Positioning), while SKHY wins 2–1 across the 6-pillar growth and valuation breakdown. SKHY trades at $122.18 (N/M Forward P/E, 76.3% operating margin) versus DRAM at $39.27 (N/M Forward P/E, N/A operating margin).
Growth vs. Quality Trade-Off: DRAM earns the overall head-to-head edge with a stronger Unified Composite Score (49.1/100 HOLD vs. SKHY 49.5/100 HOLD) and 4.02β · 102% Vol risk profile, whereas SKHY leads top-line expansion (N/A YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: SKHY is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 37.9); meanwhile DRAM is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 37.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SKHY vs DRAM. Trailing 12-month operating profitability (SKHY 76.3% vs DRAM N/A) and valuation multiples (SKHY N/M vs DRAM N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Semiconductors & Related Devices value chain with N/A market capitalization and 76.3% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
DRAM Moat ProfileCyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ SKHY vs DRAM Key Questions & Quantitative Answers
As of Nov 16, 2026, DRAM (DRAM) captures the overall head-to-head institutional edge over SK hynix Inc. (SKHY) on higher Unified Composite conviction (49.1/100 HOLD vs. 49.5/100 HOLD) after splitting the core matrix 1–3 (led by Options & Positioning), while SKHY wins 2–1 across the 6-pillar growth and valuation breakdown. SKHY trades at $122.18 (N/M Forward P/E, 76.3% operating margin) versus DRAM at $39.27 (N/M Forward P/E, N/A operating margin). Growth vs. Quality Trade-Off: DRAM earns the overall head-to-head edge with a stronger Unified Composite Score (49.1/100 HOLD vs. SKHY 49.5/100 HOLD) and 4.02β · 102% Vol risk profile, whereas SKHY leads top-line expansion (N/A YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: SKHY is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 37.9); meanwhile DRAM is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 37.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
SKHY and DRAM split Growth & Scale metrics: SKHY posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, 76.3% operating margin), compared with DRAM at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, SKHY generates N/A in USD-normalized revenue versus N/A for DRAM. In operating R&D and SG&A reinvestment, SKHY deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for DRAM.
SKHY and DRAM trade at balanced relative valuation multiples. SKHY trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin), whereas DRAM trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SKHY (N/A ROE) versus DRAM (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, SKHY carries 103.6% implied volatility (67th %ile, Elevated (60th–80th %ile)), a 1.66x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (3.17β · 99% Vol realized risk). By comparison, DRAM carries 86.4% implied volatility (74th %ile, Elevated (60th–80th %ile)), a 0.83x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (4.02β · 102% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.